Novo Nordisk A/S (NOVO:CA) Analyst/Investor Day Transcript
Novo Nordisk A/S (NOVO:CA) Analyst/Investor Day September 21, 2026 4:00 AM EDT
Company Participants
Maziar Doustdar – President, CEO & Member of the Management Board
Martin Lange – EVP of R&D, Chief Scientific Officer and Member of the Management Board
Mishal Patel
Hong Chow – Executive VP of Product & Portfolio Strategy and Member of Management Board
Daniel Bohsen
Michael Novod – Senior VP & Head of Investor Relations
Habib Bennaceur
Jamey Millar – Executive VP of US Operations & Member of Management Board
Edward Cinca
Emil Larsen – EVP of International Operations & Member of Management Board
Kasper Mejlvang – Executive Vice President of CMC & Product Supply
Karsten Knudsen – Executive VP, CFO & Member of the Management Board
Thilde Bogebjerg – Executive VP of Enterprise IT & Quality and Member of Management Board
Tania Sabroe – EVP of People, Organisation and Corporate Affairs & Member of Management Board
Conference Call Participants
Richard Vosser – JPMorgan Chase & Co, Research Division
Seamus Fernandez – Guggenheim Securities, LLC, Research Division
Michael Leuchten – Jefferies LLC, Research Division
Sachin Jain – BofA Securities, Research Division
Simon Baker – Rothschild & Co Redburn, Research Division
Florent Cespedes – ODDO BHF Corporate & Markets, Research Division
Kerry Holford – Joh. Berenberg, Gossler & Co. KG, Research Division
Carsten Madsen – Danske Bank A/S, Research Division
Graham Glyn Parry – Citigroup Inc., Research Division
Thibault Boutherin – Morgan Stanley, Research Division
James Gordon – Barclays Bank PLC, Research Division
Rajesh Kumar
Peter Verdult – BNP Paribas, Research Division
Rune Dahl – DNB Carnegie, Research Division
Emmanuel Papadakis – Deutsche Bank AG, Research Division
Conversation
Operator
Welcome to Novo’s Capital Markets Day. Before we begin, we need to advise you that this event will contain forward-looking statements. These are subject to risks and uncertainty that could cause actual results to differ materially from expectations. For further information on the risk factors, please refer to this disclaimer, which will also be available on our website.
